Skip to content

Viridian Therapeutics, Inc. VRDN Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$60.76M+3.8%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$1.21M-32.7%
PVL
Palvella TherapeuticsPVLA
$528K
TG Therapeutics logo
TG TherapeuticsTGTX
$6.48M-6.4%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
9.7%+0.1pp
Arrowhead Research logo
Arrowhead ResearchARWR
$42.79M-3.7%

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s operating lease ROU assets?
Viridian Therapeutics, Inc. (VRDN) reported operating lease ROU assets of $2.26M in Q1 2026.
How has Viridian Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Viridian Therapeutics, Inc.'s operating lease ROU assets increased by 2424731082.8% year-over-year, from $0.09 to $2.26M.
What is the long-term trend for Viridian Therapeutics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s operating lease ROU assets has grown at a 89.1% compound annual growth rate (CAGR), from $100K to $2.42M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.